Literature DB >> 29744762

Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson's disease.

Samir Hasanov1, Elif Demirkilinc Biler2, Ahmet Acarer3, Cezmi Akkın1, Zafer Colakoglu3, Onder Uretmen1.   

Abstract

PURPOSE: To evaluate and follow-up of functional and morphological changes of the optic nerve and ocular structures prospectively in patients with early-stage Parkinson's disease.
MATERIALS AND METHODS: Nineteen patients with a diagnosis of early-stage Parkinson's disease and 19 age-matched healthy controls were included in the study. All participants were examined minimum three times at the intervals of at least 6 month following initial examination. Pattern visually evoked potentials (VEP), contrast sensitivity assessments at photopic conditions, color vision tests with Ishihara cards and full-field visual field tests were performed in addition to measurement of retinal nerve fiber layer (RNFL) thickness of four quadrants (top, bottom, nasal, temporal), central and mean macular thickness and macular volumes.
RESULTS: Best corrected visual acuity was observed significantly lower in study group within all three examinations. Contrast sensitivity values of the patient group were significantly lower in all spatial frequencies. P100 wave latency of VEP was significantly longer, and amplitude was lower in patient group; however, significant deterioration was not observed during the follow-up. Although average peripapillary RNFL thickness was not significant between groups, RNFL thickness in the upper quadrant was thinner in the patient group. While there was no difference in terms of mean macular thickness and total macular volume values between the groups initially, a significant decrease occurred in the patient group during the follow-up. During the initial and follow-up process, a significant deterioration in visual field was observed in the patient group.
CONCLUSION: Structural and functional disorders shown as electro-physiologically and morphologically exist in different parts of visual pathways in early-stage Parkinson's disease.

Entities:  

Keywords:  Color vision; Contrast sensitivity; Macular thickness; Macular volume; OCT; Parkinson’s disease; RNFL thickness; VEP; Visual field analysis

Mesh:

Year:  2018        PMID: 29744762     DOI: 10.1007/s10792-018-0934-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

Review 1.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

Review 2.  Overview of the retina and imaging in patients with severe acute respiratory syndrome coronavirus 2.

Authors:  Solmaz Abdolrahimzadeh; Manuel Lodesani; Daria Rullo; Alberto Mariani; Gianluca Scuderi
Journal:  Int Ophthalmol       Date:  2022-05-11       Impact factor: 2.029

Review 3.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

Review 4.  Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?

Authors:  Yanyan Zhang; Xiaoguang Zhang; Yunhua Yue; Tian Tian
Journal:  Front Neurosci       Date:  2022-02-04       Impact factor: 4.677

5.  Evaluation of retina and microvascular changes in the patient with Parkinson's disease: A systematic review and meta-analysis.

Authors:  Yu Deng; Chuanhong Jie; Jianwei Wang; Ziqiang Liu; Yuanyuan Li; Xiaoyu Hou
Journal:  Front Med (Lausanne)       Date:  2022-09-15

6.  Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease.

Authors:  Ane Murueta-Goyena; Rocío Del Pino; Marta Galdós; Begoña Arana; Marian Acera; Mar Carmona-Abellán; Tamara Fernández-Valle; Beatriz Tijero; Olaia Lucas-Jiménez; Natalia Ojeda; Naroa Ibarretxe-Bilbao; Javier Peña; Jesus Cortes; Unai Ayala; Maitane Barrenechea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Ann Neurol       Date:  2020-11-09       Impact factor: 10.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.